Southland Equity Partners LLC
Source: SEC Form 13F · as of Mar 2026Southland Equity Partners LLC holds 12 biotech & pharma companies tracked by BioSniper, totaling $16.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$16.1M
| Company | Shares | Value |
|---|---|---|
| ABBVAbbVie Inc. | 27,285 | $5.9M |
| JNJJOHNSON & JOHNSON | 19,771 | $4.8M |
| PMPhilip Morris International Inc | 8,482 | $1.4M |
| ABTABBOTT LABORATORIES | 8,218 | $844K |
| NVSNovartis AG | 3,685 | $563K |
| LLYELI LILLY & Co | 610 | $561K |
| AMGNAMGEN INC | 1,390 | $489K |
| GILDGILEAD SCIENCES, INC. | 3,374 | $470K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,121 | $303K |
| NVONovo Nordisk A/S | 7,673 | $282K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 4,135 | $228K |
| MRKMerck & Co., Inc. | 1,837 | $221K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.